Biomarkers such as HIF-1α, vascular endothelial growth factor, glucose transporter 1, and carbonic anhydrase IX are linked to hypoxia-driven tumor behaviors and may serve as indicators of disease aggressiveness and patient outcomes. Here, VEGFA is linked to neoplasm.